Cygnus Inc

Last updated

Cygnus, Inc. was a biotechnology company that dissolved in 2007. At its inception in 1985, Cygnus was engaged in development and manufacturing of transdermal drug delivery systems, including products for contraception, hormone therapy and smoking cessation. The company also developed the GlucoWatch, a non-invasive glucose monitoring devices for manufacture and commercialization. When GlucoWatch was launched in early 2002, the product sales of GlucoWatch were much lower than expected. [1] According to the Company, the reasons for failure included adoption barriers for new technology, need for a paradigm shift in the management of diabetes, lack of widespread medical reimbursement, and performance characteristics of the device.

History

First, the GlucoWatch faced difficulties in its clinical efficacy and reproducibility of measurements. Cygnus did not resolve these technical feasibility issues [2] and was unable to replace the standard glucose monitoring device that was on the market.

Second, Cygnus lacked an effective managed care resources group. Without a substantial reimbursement level, it is very difficult for healthcare organizations to approve the GlucoWatch for its beneficiaries at the price that Cygnus was selling it. Furthermore, Cygnus failed to show the cost benefits of the device.

Third, Cygnus entered into a problematic co-promotion agreement with Sankyo Pharmaceuticals in 2000 that ended unexpectedly. Glucose monitoring products that are new to the market require a sizeable sales force to educate healthcare professionals and end user, and to create product awareness in various marketing channels. After Sankyo left the agreement, Cygnus was very low on cash and reduced the work force by 60%. Cygnus did not have enough resources or infrastructure to perform sales and marketing activities on its own.

In October 2002, the Company failed to meet the minimum price per share and minimum market capitalization listing requirements of the Nasdaq National Market and National Small Cap Market. As a result, its stock was delisted from NASDAQ and transferred to OTC bulletin board. Manufacturing activities and R&D efforts for future products were suspended. Due to Cygnus’ weak financial condition, operating losses, and lack of a marketing partner, the company's board of directors decided to sell off substantial operating assets, wind-up operations and subsequently dissolve and liquidate. [3]

In December 2004, Cygnus Inc. entered into an asset purchase agreement with Animas Corporation and Animas Technologies LLC in exchange for $10 million USD in cash. The asset sale was completed in March 2005. The Company retained some cash and equivalents, and accounts receivables but no operating assets and no means to generate revenue, other than pending arbitration with Ortho-McNeil Pharmaceutical Inc. The headquarters lease terminated and Cygnus moved to a single office in San Francisco. The arbitration with Ortho-McNeil was settled in September 2005. Ortho-McNeil paid $4 million USD in cash to Cygnus. The company had planned to wait till this settlement to file its certificate of dissolution.

In November 2005, the Company filed 10Q indicating intention to file Certification of Dissolution. As a result, trading of Company’s common stock on OTC Bulletin Board stopped. [4] The close of business was on November 21, 2005. Cygnus had never been profitable in its 17 years of history.

Related Research Articles

<span class="mw-page-title-main">Securities market</span> Component of the wider financial market

Security market is a component of the wider financial market where securities can be bought and sold between subjects of the economy, on the basis of demand and supply. Security markets encompasses stock markets, bond markets and derivatives markets where prices can be determined and participants both professional and non professional can meet.

<span class="mw-page-title-main">Nasdaq, Inc.</span> American multinational financial services corporation

Nasdaq, Inc. is an American multinational financial services corporation that owns and operates three stock exchanges in the United States: the namesake Nasdaq stock exchange, the Philadelphia Stock Exchange, and the Boston Stock Exchange, and seven European stock exchanges: Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, and Nasdaq Vilnius. It is headquartered in New York City, and its president and chief executive officer is Adena Friedman.

OTC Markets Group, Inc. is an American financial services corporation that operates a financial market providing price and liquidity information for almost 12,400 over-the-counter (OTC) securities. The group has its headquarters in New York City. OTC-traded securities are organized into three markets to inform investors of opportunities and risks: OTCQX, OTCQB and Pink.

<span class="mw-page-title-main">Adaptec</span> American computer storage company

Adaptec, Inc., was a computer storage company and remains a brand for computer storage products. The company was an independent firm from 1981 to 2010, at which point it was acquired by PMC-Sierra, which itself was later acquired by Microsemi, which itself was later acquired by Microchip Technology.

<span class="mw-page-title-main">Perrigo</span> Irish tax-registered pharmaceutical

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.

OCZ was a brand of Toshiba that was used for some of its solid-state drives (SSDs) before they were rebranded with Toshiba. OCZ Storage Solutions was a manufacturer of SSDs based in San Jose, California, USA and was the new company formed after the sale of OCZ Technology Group's SSD assets to Toshiba Corporation. Since entering the memory market as OCZ Technology in 2002, the company has targeted its products primarily at the computer hardware enthusiast market, producing performance DDR SDRAM, video cards, USB drives, power supplies, and various cooling products. SSD devices with the OCZ brand that are using SATA III, PCI Express, Serial attached SCSI and USB 3.0 interfaces, for both client and enterprise applications are currently being produced. OCZ Storage Solutions was dissolved on April 1, 2016 and absorbed into Toshiba America Electronic Components, Inc, which later then became Kioxia.

<span class="mw-page-title-main">Daiichi Sankyo</span> Japanese pharmaceutical company

Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.

<span class="mw-page-title-main">Intercontinental Exchange</span> American exchange and clearing house company

Intercontinental Exchange, Inc. (ICE) is an American multinational financial services company formed in 2000 that operates global financial exchanges and clearing houses and provides mortgage technology, data and listing services. Listed on the Fortune 500, S&P 500, and Russell 1000, the company owns exchanges for financial and commodity markets, and operates 12 regulated exchanges and marketplaces. This includes ICE futures exchanges in the United States, Canada, and Europe; the Liffe futures exchanges in Europe; the New York Stock Exchange; equity options exchanges; and OTC energy, credit, and equity markets.

Comscore, Inc. is an American-based global media measurement and analytics company providing marketing data and analytics to enterprises, advertising agencies, brand marketers, and publishers.

LifeScan, Inc. is a diagnostic systems manufacturer with products focusing on the diabetes market, specifically blood glucose monitoring systems.

China Medical Technologies, Inc. (CMED) was a Cayman Islands corporation based in China, currently in liquidation following fraud allegations. It purported to develop, manufacture, and market high intensity focused ultrasound therapy systems, advanced in vitro diagnostic ("IVD") products using enhanced chemiluminescence ("ECLIA") technology, fluorescent in-situ hybridization ("FISH") technology, and surface plasmon resonance (“SPR”) technology to detect and monitor various diseases and disorders.

Noninvasive glucose monitoring (NIGM), called Noninvasive continuous glucose monitoring when used as a CGM technique, is the measurement of blood glucose levels, required by people with diabetes to prevent both chronic and acute complications from the disease, without drawing blood, puncturing the skin, or causing pain or trauma. The search for a successful technique began about 1975 and has continued to the present without a clinically or commercially viable product.

Velti is a mobile marketing company offering its services to mobile operators and brands. The company was founded in 2001, went public in London in 2006 and on NASDAQ in 2011. In 2013 Blackstone, acquired the assets of Velti and the company was taken private.

Tobii Dynavox is a SE-based developer, manufacturer, and distributor of speech generating devices headquartered in Danderyd, Sweden, with offices in Pittsburgh, Norway, Germany, France, the UK, China, Japan, South Korea, and Taiwan. The company was formed in 1983 and produces speech communication devices and special education software used to assist individuals in overcoming speech, language and learning challenges.

GFI Group Inc. (GFI) through its subsidiaries provides brokerage services, trade execution, market data, trading platforms and other software products. Clients are institutional customers in markets for a range of fixed income, financial, equity and commodity instruments. GFI is headquartered in New York City and operates from New York, London, Paris, Tokyo, Hong Kong, Singapore and 15 other smaller financial centres such as Dublin, Nyon, Bogotá and Tel Aviv.

DexCom, Inc. is a company that develops, manufactures, produces, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has manufacturing facilities in Mesa, Arizona and Batu Kawan, Malaysia.

<span class="mw-page-title-main">Zynex</span> Medical device manufacturer

Zynex, Inc. is a medical device manufacturer that produces and markets electrotherapy devices for use in pain management, physical rehabilitation, neurological diagnosis and cardiac monitoring. Thomas Sandgaard founded Zynex Medical in 1996.

Xplore Technologies is a publicly traded, designer, marketer and manufacturer of rugged tablets. The company was founded in 1996 and is based in Austin, Texas. In 2015, Xplore Technologies purchased assets of Motion Computing making it one of the top companies in the rugged tablet PC market. The company's products are primarily used by field service personnel, factory workers and military personnel. Xplore Technologies products are built to satisfy MIL-STD-810G and HAZLOC compliant ATEX standards, as well as Ingress Protection (IP) ratings.

Nayax Ltd. is a global fintech company that offers cashless, telemetry, management, monitoring, and business intelligence (BI) products and services for the vending, unattended, and other retail industries.

Nemaura Medical Inc. is a UK based Medical Technology company developing a wireless non-invasive blood glucose monitoring system called SugarBeAT.

References

  1. ↑ Pollack, Andrew (3 November 2002). "Companies That Seek Cures Now Fight for Life". The New York Times. Retrieved 8 November 2016.
  2. ↑ "Cygnus Stock Down 17% on Product Delay". LA Times. Los Angeles Times. 12 November 1996. Retrieved 8 November 2016.
  3. ↑ Mukhey A. No action request letter. Cygnus, INC.file no. 0-18962; request for modified exchange act reporting. 2006.
  4. ↑ "Cygnus, Inc. Announces That It Intends To File Certificate Of Dissolution On November 21, 2005". BioSpace. Retrieved 8 November 2016.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.